國立虎尾科技大學 |

Bioinformatics of non small cell lung cancer and the ras proto-oncogene

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Bioinformatics of non small cell lung cancer and the ras proto-oncogene/ by Amita Kashyap, D. Bujamma, Naresh Babu M.
Author:	Kashyap, Amita.
other author:	Bujamma, D.
Published:	Singapore :Springer Singapore : : 2015.,
Description:	vii, 72 p. :ill. (some col.), digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Bioinorganic chemistry. -
Online resource:	http://dx.doi.org/10.1007/978-981-4585-08-8
ISBN:	9789814585088 (electronic bk.)

Bioinformatics of non small cell lung cancer and the ras proto-oncogene
Kashyap, Amita.

Bioinformatics of non small cell lung cancer and the ras proto-oncogene[electronic resource] /by Amita Kashyap, D. Bujamma, Naresh Babu M. - Singapore :Springer Singapore :2015. - vii, 72 p. :ill. (some col.), digital ;24 cm. - Springer briefs in applied sciences and technology. Forensic and medical bioinformatics,2191-530X. - SpringerBriefs in applied sciences and technology.Forensic and medical bioinformatics..

Introduction -- Review of Literature -- Materials and Methods (Tools and Databases) -- Flowchart -- Conclusion.-References.

Cancer is initiated by activation of oncogenes or inactivation of tumor suppressor genes. Mutations in the K-ras proto-oncogene are responsible for 10-30% of adenocarcinomas. Clinical Findings point to a wide variety of other cancers contributing to lung cancer incidence. Such a scenario makes identification of lung cancer difficult and thus identifying its mechanisms can contribute to the society. Identifying unique conserved patterns common to contributing proto-oncogenes may further be a boon to Pharmacogenomics and pharmacoinformatics. This calls for ab initio/de novo drug discovery that in turn will require a comprehensive in silico approach of Sequence, Domain, Phylogenetic and Structural analysis of the receptors, ligand screening and optimization and detailed Docking studies. This brief involves extensive role of the RAS subfamily that includes a set of proteins, which cause an over expression of cancer-causing genes like M-ras and initiate tumour formation in lungs. SNP Studies and Structure based drug discovery will also be undertaken.

ISBN: 9789814585088 (electronic bk.)

Standard No.: 10.1007/978-981-4585-08-8doiSubjects--Topical Terms:

654809
Bioinorganic chemistry.

LC Class. No.: QP531

Dewey Class. No.: 572.51

Bioinformatics of non small cell lung cancer and the ras proto-oncogene
LDR:02272nam a2200325 a 4500 001 834403
003 DE-He213
005 20150603170235.0
006 m d
007 cr nn 008maaau
008 160421s2015 si s 0 eng d
020 $a 9789814585088 (electronic bk.)
020 $a 9789814585071 (paper)
024 7 $a 10.1007/978-981-4585-08-8 $2 doi
035 $a 978-981-4585-08-8
040 $a GP $c GP
041 0 $a eng
050 4 $a QP531
072 7 $a UYQ $2 bicssc
072 7 $a COM004000 $2 bisacsh
082 0 4 $a 572.51 $2 23
090 $a QP531 $b .K19 2015
100 1 $a Kashyap, Amita. $3 1062834
245 1 0 $a Bioinformatics of non small cell lung cancer and the ras proto-oncogene $h [electronic resource] / $c by Amita Kashyap, D. Bujamma, Naresh Babu M.
260 $a Singapore : $c 2015. $b Springer Singapore : $b Imprint: Springer,
300 $a vii, 72 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Springer briefs in applied sciences and technology. Forensic and medical bioinformatics, $x 2191-530X
505 0 $a Introduction -- Review of Literature -- Materials and Methods (Tools and Databases) -- Flowchart -- Conclusion.-References.
520 $a Cancer is initiated by activation of oncogenes or inactivation of tumor suppressor genes. Mutations in the K-ras proto-oncogene are responsible for 10-30% of adenocarcinomas. Clinical Findings point to a wide variety of other cancers contributing to lung cancer incidence. Such a scenario makes identification of lung cancer difficult and thus identifying its mechanisms can contribute to the society. Identifying unique conserved patterns common to contributing proto-oncogenes may further be a boon to Pharmacogenomics and pharmacoinformatics. This calls for ab initio/de novo drug discovery that in turn will require a comprehensive in silico approach of Sequence, Domain, Phylogenetic and Structural analysis of the receptors, ligand screening and optimization and detailed Docking studies. This brief involves extensive role of the RAS subfamily that includes a set of proteins, which cause an over expression of cancer-causing genes like M-ras and initiate tumour formation in lungs. SNP Studies and Structure based drug discovery will also be undertaken.
650 0 $a Bioinorganic chemistry. $3 654809
650 0 $a Small cell lung cancer. $3 1062837
650 1 4 $a Engineering. $3 561152
650 2 4 $a Computational Intelligence. $3 768837
650 2 4 $a Computational Biology/Bioinformatics. $3 677363
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Biomedical Engineering. $3 588771
650 2 4 $a Health Informatics. $3 593963
650 2 4 $a Appl.Mathematics/Computational Methods of Engineering. $3 669335
700 1 $a Bujamma, D. $3 1062835
700 1 $a Babu M, Naresh. $3 1062836
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a SpringerBriefs in applied sciences and technology. $p Forensic and medical bioinformatics. $3 1062305
856 4 0 $u http://dx.doi.org/10.1007/978-981-4585-08-8
950 $a Engineering (Springer-11647)